Mablink Bioscience Enters an Agreement to be Acquired by Lilly
18 Oct 2023 //
GLOBENEWSWIRE
Mablink Bioscience appoints Pejvack Motlagh, M.D., as Chief Medical Officer
15 Jun 2023 //
GLOBENEWSWIRE
18 Oct 2023 //
GLOBENEWSWIRE
15 Jun 2023 //
GLOBENEWSWIRE